In 2024, Demis Hassabis and John Jumper of Google DeepMind received part of the Nobel Prize in Chemistry for their groundbreaking neural network, AlphaFold, according to MIT Technology Review. This AI system can accurately predict the three-dimensional structures of proteins by learning from thousands of experimentally measured shapes, a challenge that has persisted for over half a century.
The award marks a significant milestone in computational biology, as AlphaFold’s success represents a major leap forward from traditional experimental methods. The technology helps scientists understand protein folding, which is crucial for drug discovery and disease research, echoing the impact of pioneering figures like Albert Michelson and Stephen Hawking in their respective fields.
For Japanese markets, AlphaFold’s advancement signals growing opportunities in biotech and pharmaceutical sectors, where AI-driven innovation is becoming increasingly vital for competitive advantage and new product development.